CTMX CYTOMX THERAPEUTICS INC Capital Structure Changes 8-K Filing 2025 - Equity Offerings On May 12, 2025, CytomX Therapeutics, Inc. announced an underwriting agreement for the sale of 76,923,076 shares of common stock at $1.30 per share, aiming to raise approximately $93.4 million for research and development and working capital.Get access to all SEC 8-K filings of the CYTOMX THERAPEUTICS INC